Effect of ketorolac on serum GDF-15 and IL-8 in patients with pancreatic cancer with cachexia. Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback